{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:27:21Z","timestamp":1783744041400,"version":"3.55.0"},"reference-count":22,"publisher":"Informa UK Limited","issue":"6","license":[{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Inc.","doi-asserted-by":"crossref","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2020,6,2]]},"DOI":"10.1080\/21645515.2020.1744363","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T23:59:02Z","timestamp":1589414342000},"page":"1272-1279","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and safety of a booster dose of the meningococcal A, C, W, Y-tetanus toxoid conjugate vaccine administered 10 years after primary vaccination and long-term persistence of tetanus toxoid conjugate or polysaccharide vaccine"],"prefix":"10.1080","volume":"16","author":[{"given":"Beatriz","family":"Quiambao","sequence":"first","affiliation":[{"name":"Clinical Research Division, Research Institute for Tropical Medicine, Alabang, Muntinlupa City, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Peyrani","sequence":"additional","affiliation":[{"name":"Pfizer Vaccine Clinical Research and Development, Pfizer Inc, Collegeville, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[{"name":"Pfizer Vaccine Clinical Research and Development, Pfizer Inc, Collegeville, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Cutler","sequence":"additional","affiliation":[{"name":"Pfizer Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Van Der Wielen","sequence":"additional","affiliation":[{"name":"Vaccines R & D, GlaxoSmithKline, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Perez","sequence":"additional","affiliation":[{"name":"Pfizer Vaccine Clinical Research and Development, Pfizer Inc, Collegeville, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Webber","sequence":"additional","affiliation":[{"name":"Pfizer Vaccine Clinical Research and Development, Pfizer Inc, Hurley, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,5,13]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1086\/648963"},{"key":"cit0002","unstructured":"Centers for Disease Control and Prevention. Chapter 14: meningococcal disease. Public Health Foundation; [accessed 2020 Jan 28] https:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/downloads\/mening.pdf."},{"key":"cit0003","volume-title":"Chapter 8: meningococcal disease. Manual for the surveillance of vaccine-preventable diseases","author":"MacNeil J","year":"2017","edition":"5"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1258308"},{"key":"cit0005","volume-title":"Summary of product characteristics","author":"Nimenrix\u00ae: EPAR - product information","year":"2019"},{"key":"cit0006","volume-title":"Full prescribing information","author":"Mencevax\u00ae ACWY (meningococcal ACWY vaccine)","year":"2015"},{"key":"cit0007","unstructured":"Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Briere EZ, Meer HC, Baker CJ, Messonnier NE. Prevention and control of meningococcal disease: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep; [accessed 2020 Feb 3] https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr6202a1.htm."},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-2193"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000897"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.159.10.907"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2012.04.006"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.4161\/hv.7.2.14068"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1163455"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1248009"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1136040"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000866"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2014.02.025"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2012.10.001"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318279ac38"},{"key":"cit0020","volume-title":"Paper presented at: 37th Annual Meeting of the European Society of Paediatric Infectious Diseases","author":"Peyrani P","year":"2019"},{"key":"cit0021","volume-title":"National Center for Immunization and Respiratory Diseases Office of Infectious Diseases. Enhanced meningococcal disease surveillance report, 2017 (CS283195)","year":"2017"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70251-6"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2020.1744363","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T20:44:49Z","timestamp":1629233089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2020.1744363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,13]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6,2]]}},"alternative-id":["10.1080\/21645515.2020.1744363"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2020.1744363","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-12-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}